文献速递炎症性肠病消化道肿瘤与早癌

综述:噬菌体在胃肠病学中的应用——从生物学到临床

Review article: bacteriophages in gastroenterology-from biology to clinical applications.
PubMed 文献 · Aliment Pharmacol Ther · 2019-11-07

本文综述噬菌体生物学及其在胃肠病学中的临床应用。通过检索PubMed相关研究,总结噬菌体可裂解细菌、整合DNA或与细菌共存,噬菌体疗法在霍乱等感染病及艰难梭菌结肠炎、克罗恩病、结直肠癌中探索,安全性良好,克罗恩病随机对照试验正在进行。

要点

  • 噬菌体通过裂解细菌、整合DNA或稳定共存调节细菌群落。
  • 噬菌体疗法在胃肠病学主要用于感染性疾病如霍乱。
  • 噬菌体疗法安全性良好,克罗恩病随机对照试验正在进行。

核心结论

  • 噬菌体疗法是针对病原菌的有前景治疗工具,在感染病和胃肠病学领域具有潜力。
  • 针对胃肠病的随机安慰剂对照试验正在进行中。

研究设计与样本

  • 综述类文章,通过检索PubMed识别相关研究。

主要发现

  • 噬菌体可诱导细菌裂解、将病毒DNA整合到细菌中或与细菌稳定共存。
  • 细菌与噬菌体共同进化,其动态相互作用尚未完全理解。
  • 调节微生物群落的需求促进噬菌体作为抗菌疗法的研究。
  • 在胃肠病学中,噬菌体疗法主要研究于感染性疾病如霍乱。
  • 目前正在探索治疗艰难梭菌结肠炎、靶向克罗恩病中的黏附侵袭性大肠杆菌或根除结直肠癌中的具核梭杆菌。

临床怎么用

  • 噬菌体疗法可作为针对病原菌的潜在治疗选择,尤其在感染病和胃肠病学领域。
  • 临床可关注噬菌体疗法在艰难梭菌结肠炎、克罗恩病和结直肠癌中的研究进展。

局限性

  • 细菌与噬菌体的动态相互作用尚未完全理解。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The gut microbiota plays an important role in the pathogenesis of several gastrointestinal diseases. Its composition and function are shaped by host-microbiota and intra-microbiota interactions. Bacteriophages (phages) are viruses that target bacteria and have the potential to modulate bacterial communities. AIMS: To summarise phage biology and the clinical applications of phages in gastroenterology METHODS: PubMed was searched to identify relevant studies. RESULTS: Phages induce bacterial cell lysis, integration of viral DNA into the bacteria and/or coexistence in a stable equilibrium. Bacteria and phages have co-evolved and their dynamic interactions are yet to be fully understood. The increasing need to modulate microbial communities (e.g., gut microbiota, multidrug-resistant bacteria) has been a strong stimulus for research in phages as an antibacterial therapy. In gastroenterology, phage therapy has been mainly studied in infectious diseases such as cholera. However, it is currently being explored in several other circumstances such as treating Clostridioides difficile colitis, targeting adherent-invasive Escherichia coli in Crohn's disease or eradicating Fusobacterium nucleatum in colorectal cancer. Overall, phage therapy has a favourable and acceptable safety profile. Presently, trials with phage therapy are ongoing in Crohn's disease. CONCLUSIONS: Phage therapy is a promising therapeutic tool against pathogenic bacteria in the fields of infectious diseases and gastroenterology. Randomised, placebo-controlled trials with phage therapy for gastroenterological diseases are ongoing.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Sabino J, Hirten RP, Colombel JF, et al. Review article: bacteriophages in gastroenterology-from biology to clinical applications. Aliment Pharmacol Ther. 2019. PMID: 31696976. doi:10.1111/apt.15557

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。